Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-cholest-en-3-one, oxime |
---|---|
Date Designated: | 12/01/2005 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Trophos SA Parc scientifique de Lumigny, Case 931 1322 Marseille cedex France The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-